País: Austrália
Língua: inglês
Origem: Department of Health (Therapeutic Goods Administration)
donepezil hydrochloride monohydrate, Quantity: 5.21 mg (Equivalent: donepezil hydrochloride, Qty 5.21 mg)
Cipla Australia Pty Ltd
donepezil hydrochloride monohydrate
Tablet, film coated
Excipient Ingredients: lactose monohydrate; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000
Oral
28 tablets, 14 tablets, 7 tablets
(S4) Prescription Only Medicine
CIPLA DONEPEZIL (donepezil hydrochloride) is indicated for the treatment of mild, moderate and severe Alzheimer's disease.
Visual Identification: White coloured circular, biconvex film-coated tablets with "5" debossed on one side and "DPZ" debossed on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2015-12-18